Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
about
An important role for autoimmunity in the immunopathogenesis of chronic allograft rejectionSignificance of T helper 17 immunity in transplantationVascular endothelium as a target of immune response in renal transplant rejectionModels of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.Efficacy of extracorporeal photopheresis in clearance of antibodies to donor-specific and lung-specific antigens in lung transplant recipients.Antibodies to MHC class II molecules induce autoimmunity: critical role for macrophages in the immunopathogenesis of obliterative airway disease.Nitric oxide sustains IL-1β expression in human dendritic cells enhancing their capacity to induce IL-17-producing T-cells.De novo-developed antibodies to donor MHC antigens lead to dysregulation of microRNAs and induction of MHC class IIDe novo development of antibodies to kidney-associated self-antigens angiotensin II receptor type I, collagen IV, and fibronectin occurs at early time points after kidney transplantation in children.Protein-DNA array-based identification of transcription factor activities differentially regulated in obliterative bronchiolitis.Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantationElevated Circulating Interleukin 33 Levels in Stable Renal Transplant Recipients at High Risk for Cardiovascular Events.Inhibition of renin angiotensin aldosterone system causes abrogation of obliterative airways disease through inhibition of tumor necrosis factor-α-dependant interleukin-17.Critical role for IL-17A/F in the immunopathogenesis of obliterative airway disease induced by Anti-MHC I antibodies.Bronchiolitis obliterans syndrome: the Achilles' heel of lung transplantation.IL-17 induces type V collagen overexpression and EMT via TGF-β-dependent pathways in obliterative bronchiolitis.Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link?Pre-transplant antibodies to Kα1 tubulin and collagen-V in lung transplantation: clinical correlations.Role of complement activation in obliterative bronchiolitis post-lung transplantation.Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154.Autologous and Allogenous Antibodies in Lung and Islet Cell Transplantation.Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.Antibodies against Apoptotic Cells Present in End-stage Lung Disease Patients Do Not Correlate with Clinical Outcome after Lung Transplantation.Phenotypes of antibody-mediated rejection in organ transplants.The impact of infection and tissue damage in solid-organ transplantation.Prediction of organ transplant rejection by HLA-specific and non-HLA antibodies--brief literature review.Role of antibodies to self-antigens in chronic allograft rejection: potential mechanism and therapeutic implications.Chronic rejection: a significant role for Th17-mediated autoimmune responses to self-antigens.CD4(+) T-cell subsets in transplantation.Immune responses to self-antigens (autoimmunity) in allograft rejection.Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection.Antibody-mediated graft injury: complement-dependent and complement-independent mechanisms.Lung transplantation: chronic allograft dysfunction and establishing immune tolerance.Characteristic patterns in the fibrotic lung. Comparing idiopathic pulmonary fibrosis with chronic lung allograft dysfunction.The importance of non-HLA antibodies in transplantation.Basement membranes and autoimmune diseases.Airway remodelling in the transplanted lung.Immune Responses to Tissue-Restricted Nonmajor Histocompatibility Complex Antigens in Allograft RejectionPolyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation.Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection.
P2860
Q26827623-3024055C-5145-47B2-89BA-CE058B19E8A7Q26998887-45126F8A-4D93-4236-A66F-272AD5AEE235Q27024077-21C74B7C-3291-426D-AD8F-FEF15E3B02EAQ30352802-72331272-04AF-4B74-83DC-3F293AFC9600Q34036197-692A6A96-CFB9-499B-88B9-354D8C3776AFQ34382434-E846B8E2-DC3B-4DFB-AA8F-51889B5CBA01Q35327027-3CA51B1B-598F-4001-8840-7BD8D046F731Q35691072-69A379C6-5369-434E-8430-02446F438E00Q35798183-1A678DB3-12AF-49B4-A6B4-684FAEE5D0ADQ35919314-3266B238-8BC5-45F2-835D-0E955A67B2ABQ36131035-5EDCE630-AAB2-4195-B6B9-4B50B2A07A6DQ36257484-073A0175-253E-402C-BAE6-64A6B6DBDB51Q36292047-42F116AF-ECF5-4232-B845-DC6D636EB853Q36547137-D6B0442B-7B24-422C-9F27-9B0D02E49FE7Q36623201-5F8652F3-067D-412A-A80F-24CA0C1879F0Q36699993-F6756FB6-AC80-4127-912E-066F7C8EC1F0Q36703898-A25DEE49-0D57-4C33-9740-49FE988592C8Q37149537-DC1F9382-024F-42E1-94FC-40C4790C51D6Q37414751-1E90D063-CB7D-464E-A66C-43D663347231Q37423395-819E0360-449A-4FF2-AD64-71A2E8D6F868Q37528715-28847A06-7906-419E-AF72-E666E7A20D6BQ37688479-0DF4B211-B94B-4917-A57B-CE17F100801AQ37712485-1801AD6A-5DBD-4132-AE9A-1863D9F8E988Q38005448-6135E930-B5B8-4CA6-A776-C1BFDD278909Q38013050-E9228BD5-2020-4B99-9E84-553C348DFE3BQ38019584-5FE80B9D-2469-4DC6-A522-195E015377A5Q38025804-5B737CC8-1D42-49AD-9B4A-801AB5AE8F55Q38053174-3AED72F5-0BCC-4F15-ADD6-E93CC1FA8D4DQ38081174-947025F7-F149-4E7E-BB6A-EFBBAF2CB83BQ38110566-D4C67682-3F8C-496E-A2DC-A1DEB46E5E58Q38123309-5BC85091-0826-4A62-8745-663AD184EFD3Q38169496-FB9FED54-9952-4CF1-B233-B44FC25EED49Q38224758-4CB47282-D8B1-4C90-9F9F-1948A32E9079Q38399493-EF8F9CD8-CE7D-4B2C-880B-8E196316C7EBQ38877375-F3D1FC76-964E-47FF-94EB-3AD9E3796FC8Q38920115-50C1C2F8-EFF8-4F44-897D-A6725B6EF96EQ39006011-423AED53-7B68-4BB0-BDE2-8858AE7E884EQ39121365-F44410AA-2D34-4CD0-B3D0-60717A813EC8Q39207543-ACA8C85A-A223-4618-B892-937F5F2F6D3EQ39217968-F1BC8ACB-373D-4663-8CC4-8E380E13EA39
P2860
Alloimmunity-induced autoimmunity as a potential mechanism in the pathogenesis of chronic rejection of human lung allografts.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@ast
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@en
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@nl
type
label
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@ast
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@en
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@nl
prefLabel
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@ast
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@en
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@nl
P2093
P2860
P1476
Alloimmunity-induced autoimmun ...... tion of human lung allografts.
@en
P2093
Aviva Aloush
Bryan Meyers
Deepti Saini
Donna Phelan
Elbert Trulock
G Alexander Patterson
Joseph Weber
Michael Liu
Nancy Steward
Ramsey Hachem
P2860
P304
P356
10.1016/J.HEALUN.2011.01.708
P577
2011-03-16T00:00:00Z